Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q4Q591
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 9 |
GO:0005515 | protein binding | 2 | 9 |
GO:0046982 | protein heterodimerization activity | 4 | 9 |
GO:0046983 | protein dimerization activity | 3 | 9 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.536 |
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.588 |
CLV_PCSK_KEX2_1 | 154 | 156 | PF00082 | 0.586 |
CLV_PCSK_PC1ET2_1 | 154 | 156 | PF00082 | 0.586 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.569 |
CLV_PCSK_SKI1_1 | 96 | 100 | PF00082 | 0.489 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.622 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.607 |
DOC_USP7_MATH_1 | 147 | 151 | PF00917 | 0.532 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.481 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.516 |
LIG_14-3-3_CanoR_1 | 125 | 129 | PF00244 | 0.505 |
LIG_FHA_1 | 102 | 108 | PF00498 | 0.417 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.588 |
LIG_LIR_Gen_1 | 24 | 31 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 24 | 30 | PF02991 | 0.485 |
LIG_SH2_NCK_1 | 27 | 31 | PF00017 | 0.471 |
LIG_SH2_STAP1 | 27 | 31 | PF00017 | 0.471 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.462 |
LIG_SUMO_SIM_anti_2 | 104 | 109 | PF11976 | 0.422 |
LIG_UBA3_1 | 145 | 154 | PF00899 | 0.519 |
MOD_CK1_1 | 123 | 129 | PF00069 | 0.590 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.718 |
MOD_CK1_1 | 35 | 41 | PF00069 | 0.689 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.451 |
MOD_GlcNHglycan | 14 | 18 | PF01048 | 0.706 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.650 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.506 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.612 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.539 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.655 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.671 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.526 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.572 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.531 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.482 |
MOD_NEK2_2 | 63 | 68 | PF00069 | 0.505 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.495 |
MOD_PIKK_1 | 6 | 12 | PF00454 | 0.607 |
MOD_PKA_1 | 118 | 124 | PF00069 | 0.562 |
MOD_PKA_1 | 32 | 38 | PF00069 | 0.583 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.646 |
MOD_PKA_2 | 124 | 130 | PF00069 | 0.532 |
MOD_Plk_1 | 17 | 23 | PF00069 | 0.682 |
TRG_ENDOCYTIC_2 | 27 | 30 | PF00928 | 0.475 |
TRG_ER_diArg_1 | 155 | 157 | PF00400 | 0.496 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ICI0 | Leptomonas seymouri | 65% | 100% |
A0A0S4KIL7 | Bodo saltans | 35% | 100% |
A0A3S7X5N4 | Leishmania donovani | 92% | 100% |
A4HKH6 | Leishmania braziliensis | 73% | 100% |
A4I803 | Leishmania infantum | 92% | 100% |
D0AA70 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9B2W5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |